This Week in Pharmacy

✓

مطالبة

October 23, 2026 Sponsored by Independent Pharmacy Cooperative and YARAL Pharma This week on TWIRx: peptide compounding policy, a new hepatitis B treatment, specialty pharmacy growth, a rare-disease breakthrough, and pharmacy workforce pressure — followed by three conversations focused on the futu…

Cell and gene therapy has entered a new phase. The science is advancing rapidly, but the harder question is increasingly becoming: How do we actually get these therapies to the right patient, at the right treatment center, with the financing, logistics, clinical support, and follow-up required?   …

This week on TWIRx, we head into NCPA 2026 with independent community pharmacy front and center — from artificial intelligence and consolidation to supply-chain economics and policy reform.   We start with the TWIRx Rumor Mill — Behind the Counter Intelligence, looking at three developing stories…

In this special episode of This Week in Pharmacy, Todd Eury welcomes Vox, the PPN and RxPR Intelligence Officer, for a timely conversation about the forces reshaping pharmacy. Together, they examine the reimbursement pressures threatening independent pharmacies, the progress—and unfinished work—of…

In this IPC-sponsored episode, Todd Eury explores how manufacturer-direct programs, direct-to-consumer channels, cash-pay models, specialty carve-outs, and new reimbursement structures are reshaping medication access and independent pharmacy.   Joining the conversation are Shelley Bailey of Indep…

This week on TWIRx, we’re looking at the expanding role of pharmacists in public health, value-based care, artificial intelligence, medication intelligence, and the technology infrastructure supporting independent community pharmacy.   We begin with a special conversation featuring Alex J. Adams,…

Specialty Pharmacy Access, Innovation & Independent Pharmacy Growth   This Week in Pharmacy, we explore specialty pharmacy, pharmacy innovation, emerging career opportunities, and new business models for independent community pharmacy.   Today’s episode is sponsored by Clearway Health, Value…

TWIRx NEWS 1. Medicare Part D Paid Nearly $588 Million for Ineligible OTC Drugs   A federal audit found that Medicare Part D sponsors made approximately $587.7 million in ineligible payments from 2021 through 2023 for medications that had effectively transitioned from prescription to over-the-coun…

Today’s episode of This Week in Pharmacy — #TWIRx is sponsored by Value Drug Company and explores two major forces reshaping pharmacy: the evolution of the community pharmacy business model and the expanding role of artificial intelligence in medication optimization and value-based care.   PART ONE…